Diabetes Care, Vol 18, Issue 12 1606-1618, Copyright © 1995 by American Diabetes Association

ARTICLES

Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations

MM Engelgau, RE Aubert, TJ Thompson and WH Herman
Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA 30341-3724, USA. mxe1@cdddt1.em.cdc.gov

The economic burden of diabetes in the U.S. is now more than 90 billion dollars per year (113-115). In the diabetes community, there is a feeling that aggressive measures to detect diabetes in earlier stages may be warranted. Regardless of whether evidence is convincing that there are benefits from early detection of diabetes (3,116,117), screening activities have been sanctioned by many organizations and are now taking place. Operational research is needed to define more clearly the who, when, where, and how of screening and the effectiveness of screening programs (4,118). Diabetes screening programs should be comprehensive and should educate about diabetes and provide appropriate interpretation of both positive and negative screening results. It is essential that programs have diagnostic follow-up and refer those with newly diagnosed diabetes for treatment. In addition, individuals with previously diagnosed diabetes encountered during screening activities should be made aware of the importance of glycemic control and follow-up with their health care providers.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Dankner, G. Geulayov, L. Olmer, and G. Kaplan Undetected type 2 diabetes in older adults Age Ageing, November 13, 2008; (2008) afn218v1. [Abstract] [Full Text] [PDF]

				T. J. Hoerger, R. Harris, K. A. Hicks, K. Donahue, S. Sorensen, and M. Engelgau Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis Ann Intern Med, May 4, 2004; 140(9): 689 - 699. [Abstract] [Full Text] [PDF]

				R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]

				P.J. Park, S.J. Griffin, L. Sargeant, and N. J. Wareham The Performance of a Risk Score in Predicting Undiagnosed Hyperglycemia Diabetes Care, June 1, 2002; 25(6): 984 - 988. [Abstract] [Full Text] [PDF]

				D. B. Rolka, K. M. V. Narayan, T. J. Thompson, D. Goldman, J. Lindenmayer, K. Alich, D. Bacall, E. M. Benjamin, B. Lamb, D. O. Stuart, et al. Performance of Recommended Screening Tests for Undiagnosed Diabetes and Dysglycemia Diabetes Care, November 1, 2001; 24(11): 1899 - 1903. [Abstract] [Full Text] [PDF]

				N. J Wareham and S. J Griffin Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria BMJ, April 21, 2001; 322(7292): 986 - 988. [Full Text]

				S. H. Saydah, C. M. Loria, M. S. Eberhardt, and F. L. Brancati Subclinical States of Glucose Intolerance and Risk of Death in the U.S. Diabetes Care, March 1, 2001; 24(3): 447 - 453. [Abstract] [Full Text]

				D. Perucchini, U. Fischer, G. A Spinas, R. Huch, A. Huch, and R. Lehmann Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study BMJ, September 25, 1999; 319(7213): 812 - 815. [Abstract] [Full Text]

				E. Goyder, L. Irwig, E. Kessel, M. M. Engelgau, K. M. V. Narayan, D. F. Williamson, T. J. Thomson, and F. Dong Screening for Type 2 Diabetes JAMA, June 2, 1999; 281(21): 1986 - 1988. [Full Text] [PDF]

				The CDC Diabetes Cost-Effectiveness Study Group The Cost-effectiveness of Screening for Type 2 Diabetes JAMA, November 25, 1998; 280(20): 1757 - 1763. [Abstract] [Full Text] [PDF]

				AADE Position Statement: Educating Providers and Persons With Diabetes to Prevent the Transmission of Bloodborne Infections and Avoid Injuries From Sharps The Diabetes Educator, January 1, 1997; 23(4): 401 - 403. [PDF]